Two New FDA-Approved Bladder and Bowel Control Therapies
Medtronic plc, has received approval from the US FDA for its InterStim™ Micro neurostimulator and InterStim™ SureScan™ MRI leads.More than 37 million adults in the United States suffer from overactive bladder (OAB), and nearly 18 million Americans have bowel incontinence. Many...
Latest News
Company Recognises Nurses with Charitable Contribution
UK company Single Use Surgical Ltd (SUSL) will donate 5p from the sale of every disposable surgical...
read the full article >Cardiology
First Scoring Guidelines Validated for WatchPAT™ Sleep Apnea Diagnostic
Respiratory Sleep Disorder specialist, Itamar Medical Ltd. has announced publication of results of...
read the full article >
Revivent TC Less Invasive Ventricular Enhancement Therapy CE Mark Extended to 2024
read the full article >Promise for Emboliner™ Embolic Protection Catheter as Safepass 2 Study Completes Enrollment
Emboline™, Inc., developer of total embolic protection technology for transcatheter aortic valve...
read the full article >Approvals / Clearance
CE Mark for Ortho's COVID-19 IgG Antibody Test
A few weeks ago we reported that Ortho Clinical Diagnostics had seen its COVID-19 total antibody...
read the full article >
Clinical Studies / Trials
Rezūm™ Water Vapor BPH Therapy Effective After Five Years
New clinical study results say the Rezūm System provided significant, sustained improvement of...
read the full article >First Patient in SELUTION SLR™ Study for AV Fistula
MedAlliance has announced enrollment of the first patient in the SAVE* study utilizing their novel...
read the full article >